N
MDGL icon

Natixis’s Madrigal Pharmaceuticals MDGL Stock Holding History

Natixis’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,041
Closed -$606K – 1246
2025
Q4 		$606K Buy
+1,041
New +$532K ﹤0.01% 802
2024
Q1 		– Sell
-857
Closed -$198K – 1140
2023
Q4 		$198K Sell
857
-45
-5% -$7.87K ﹤0.01% 717
2023
Q3 		$132K Buy
+902
New +$170K ﹤0.01% 757
2023
Q2 		– Sell
-1,109
Closed -$269K – 1091
2023
Q1 		$269K Buy
+1,109
New +$302K ﹤0.01% 709
2021
Q2 		– Sell
-22,000
Closed -$2.57M – 915
2021
Q1 		$2.57M Sell
22,000
-31,722
-59% -$3.7M 0.01% 638
2020
Q4 		$5.97M Sell
53,722
-25,412
-32% -$3.11M 0.02% 484
2020
Q3 		$9.4M Buy
+79,134
New +$8.59M 0.07% 196

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return